Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices
This article was originally published in The Tan Sheet
Executive Summary
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole